Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer.
about
Bisphosphonates for advanced prostate cancerMolecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?Bisphosphonates for the relief of pain secondary to bone metastases.Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care.The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate.The potential role of bisphosphonates in prostate cancer.Advances in the use of bisphosphonates in the prostate cancer setting.Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancerMarkers of bone turnover for the management of patients with bone metastases from prostate cancerZoledronic acid in the management of metastatic bone disease.Assessing pharmacological interventions for bone metastases: the need for more patient-centered outcomes.Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors.Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project.Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancy.Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancerThe use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers.Bisphosphonates for advanced prostate cancer.Management of the side effects of androgen deprivation therapy in men with prostate cancer
P2860
Q24244161-B30C42F5-4962-40A8-86B4-CA0F0A914C84Q28068956-9DEDD10E-4C30-4E10-8628-7F9AB22E6525Q32139406-07914EC0-E485-49FD-8105-1ACD0D4408D6Q34162842-CC89B1C9-2895-477A-A552-22DDF1E5C6F5Q35004491-91C44B72-1762-4A96-8B29-0B3B2C4E483FQ35081743-D972957B-42AB-482E-8DC1-2A8F08521721Q35679766-9F43B61F-705D-47AF-9141-22927B9A163FQ36431182-D80AEF56-8608-4157-9296-510F41981C2DQ36641310-4CAC66E6-6B6C-48F6-BEC2-47224267201CQ36708315-75B94622-1B7B-448F-9E3E-8DA21CEFBD89Q38018675-C4552BF9-D62E-4965-B56B-A8E8DF721A70Q38040123-51B7F795-0451-4528-979C-A4D273F162BCQ38785899-3EEAC236-AF7C-48CF-B8D3-37237EA88B45Q40405369-752C3351-EAB3-46EC-B8AA-C9A3839CDD5BQ42002897-74F6E0DC-11A5-4914-8BA9-22E9535CE337Q46832072-3E1CE696-06B1-41E6-85EB-FA1D3CA5BB15Q47248454-9E2ED3E3-39CA-4243-893D-32D388D14FECQ57143367-09C88C14-E73A-456F-93ED-57ECF1F61FB4
P2860
Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Effect of oral clodronate on b ...... ith metastic prostatic cancer.
@en
Effect of oral clodronate on b ...... ith metastic prostatic cancer.
@nl
type
label
Effect of oral clodronate on b ...... ith metastic prostatic cancer.
@en
Effect of oral clodronate on b ...... ith metastic prostatic cancer.
@nl
prefLabel
Effect of oral clodronate on b ...... ith metastic prostatic cancer.
@en
Effect of oral clodronate on b ...... ith metastic prostatic cancer.
@nl
P2093
P356
P1476
Effect of oral clodronate on b ...... ith metastic prostatic cancer.
@en
P2093
J Seppänen
J Viitanen
K Jauhiainen
M Ala-Opas
P304
P356
10.1007/BF02549644
P577
1992-01-01T00:00:00Z